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Interventional Cardiology
Periprocedural Bleeding Is a Robust Risk Marker for Post-PCI Mortality
Traditionally, the composite triple end point used to assess PCI procedures is thecombined incidence of death, myocardial infarction (MI), and urgent revascu-
larization (UR) at 30days.Recently, some studies have used a quadruple endpoint that
includes periprocedural bleeding complications. Ndrepepa and colleagues combined
data from the 4 ISAR trials to investigate the relationship between bleeding and 1-year
mortality. The hazard ratio for 1-year mortality was 3.0 for bleeding, 2.3 for MI, and
2.5 for UR; all 3 outcomes had similar discriminatory power. This study demonstrates
a strong relationship between periprocedural bleeding and 1-year mortality and sup-
ports the inclusion of periprocedural bleeding in a 30-day quadruple end point.
See pages 690 and 698. See figure.
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Interventional Cardiology
The Problem With Composite End Points
The term MACE (major adverse cardiac events) is a commonly used end point for
cardiovascular research; however, there is no standard definition for MACE. Kip and
colleagues conducted a 2-phase literature review on the use of MACE as a composite
end point, and then simulated different definitions of MACE in a large percutaneous
coronary intervention registry. The review identified substantial heterogeneity in the
outcomes used to define MACE; these different definitions of MACE significantly
altered the apparent efficacy of various interventions. The authors conclude that the
term MACE should not be used unless a standard definition can be agreed upon.
See page 701. See figure.
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Lipids and CAD
Lower TGs Improve Outcomes in Post-ACS Patients
The risk associated with elevated triglycerides (TGs) in patients achieving optimal
low-density lipoprotein (LDL) reduction is unclear. Miller and colleagues studied the
effect of TG levels on outcomes in patients enrolled in the PROVE IT-TIMI 22 trial,
which randomizedpost–acute coronary syndrome (ACS)patients to either atorvastatin
80 mg/day or pravastatin 40 mg/day. Subjects with TG150 mg/dl were at reduced
risk for future events, independent of the LDL level. Those with LDL70mg/dl and
TG150mg/dl were at the lowest risk. These data suggest that both LDL cholesterol
and TG levels are important therapeutic parameters in patients following ACS.
See page 724. See figure.
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Heart Rhythm Disorders
EVM Can Distinguish ARVD From RVOT
It can be difficult to distinguish the fairly benign right ventricular outflow tract
(RVOT) tachycardia from the more dangerous arrhythmogenic right ventricular
cardiomyopathy/dysplasia (ARVC/D). Corrado and colleagues performed right ven-
tricular electroanatomic voltage mapping (EVM), using a CARTO system, in 27
patients withRVOT tachycardia andmorphologically normal right ventricles. In 26%
of patients, they identified areas of low signal amplitude; these patientsweremore likely
to have fibrofatty replacement of the myocardium on biopsy. Forty three percent of
these patients went on to require an implantable cardioverter-defibrillator, versus none
of the patients with normal EVMs. Electroanatomic voltage mapping may be a valid
method for distinguishing early or minor ARVC/D from idiopathic RVOT tachycar-
dia. See pages 731 and 740. See figure.
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Pulmonary Hypertension
Prolonged RV Contraction Causes Septal Bowing in PAH Patients
In pulmonary arterial hypertension (PAH), leftward ventricular septal bowing (LVSB)
is most prominent in early diastole and seems to be caused by a relative delay in
maximal right ventricle (RV) pressure. However, it is not clear if this delay is caused by
delayed onset of RV contraction or prolonged RV contraction.Marcus and colleagues
studied patientswith PAHusing cinemagnetic resonance imaging.Therewas no delay
in the onset of contraction in the RV; however, peak RV free wall strain occurred 120
ms after the peak strain in the septum and 59ms after closure of the pulmonic valve. In
PAH, LVSB is caused by lengthening of the duration of RV contraction, which results
in decreased left ventricle filling and, therefore, decreased stroke volume. See pages
750 and 758. See figure.
